Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag on the page updated from v3.6.4 to v3.6.5, signaling a new internal revision of the Study Details page. No changes to study data, eligibility criteria, or results are indicated by this update.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the study record on ClinicalTrials.gov. This update appears to be a metadata/version-control change rather than a modification to the study content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows revision v3.6.3, replacing the previous v3.6.0. This reflects an internal update to the page rendering rather than changes to the trial data.SummaryDifference0.1%

- Check76 days agoChange DetectedNew user-facing sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated. The recruitment status now shows No longer looking for participants, and the revision tag was updated from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.5%

- Check84 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a system or interface update. It does not alter the study details or data presented.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a newer version of the page content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.